{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:57:05Z","timestamp":1788375425377,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tauopathy, characterized by the hyperphosphorylation and accumulation of the microtubule-associated protein tau, and the accumulation of A\u03b2 oligomers, constitute the major pathological hallmarks of Alzheimer\u2019s disease. However, the relationship and causal roles of these two pathological changes in neurodegeneration remain to be defined, even though they occur together or independently in several neurodegenerative diseases associated with cognitive and movement impairment. While it is widely accepted that A\u03b2 accumulation leads to tauopathy in the late stages of the disease, it is still unknown whether tauopathy influences the formation of toxic A\u03b2 oligomers. To address this, we generated transgenic cynomolgus monkey models expressing Tau (P301L) through lentiviral infection of monkey embryos. These monkeys developed age-dependent neurodegeneration and motor dysfunction. Additionally, we performed a stereotaxic injection of adult monkey and mouse brains to express Tau (P301L) via AAV9 infection. Importantly, we found that tauopathy resulting from embryonic transgenic Tau expression or stereotaxic brain injection of AAV-Tau selectively promoted the generation of A\u03b2 oligomers in the monkey spinal cord. These A\u03b2 oligomers were recognized by several antibodies to A\u03b21\u201342 and contributed to neurodegeneration. However, the generation of A\u03b2 oligomers was not observed in other brain regions of Tau transgenic monkeys or in the brains of mice injected with AAV9-Tau (P301L), suggesting that the generation of A\u03b2 oligomers is species- and brain region-dependent. Our findings demonstrate for the first time that tauopathy can trigger A\u03b2 pathology in the primate spinal cord and provide new insight into the pathogenesis and treatment of tauopathy.<\/jats:p>","DOI":"10.1038\/s41392-023-01601-6","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:01:52Z","timestamp":1695340912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys"],"prefix":"10.1038","volume":"8","author":[{"given":"Zhuchi","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-1570","authenticated-orcid":false,"given":"Sen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weien","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmeng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-6536","authenticated-orcid":false,"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"1601_CR1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","volume":"101","author":"LI Binder","year":"1985","unstructured":"Binder, L. I., Frankfurter, A. & Rebhun, L. I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371\u20131378 (1985).","journal-title":"J. Cell Biol."},{"key":"1601_CR2","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1242\/jcs.01531","volume":"117","author":"A Samsonov","year":"2004","unstructured":"Samsonov, A., Yu, J. Z., Rasenick, M. & Popov, S. V. Tau interaction with microtubules in vivo. J. Cell Sci. 117, 6129\u20136141 (2004).","journal-title":"J. Cell Sci."},{"key":"1601_CR3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","volume":"12","author":"M Shi","year":"2016","unstructured":"Shi, M. et al. Cns tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Alzheimers Dement. 12, 1125\u20131131 (2016).","journal-title":"Alzheimers Dement."},{"key":"1601_CR4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee, V. M., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121\u20131159 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"1601_CR5","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/mds.20539","volume":"12","author":"M Goedert","year":"2005","unstructured":"Goedert, M. Tau gene mutations and their effects. Mov. Disord. 12, S45\u2013S52 (2005).","journal-title":"Mov. Disord."},{"key":"1601_CR6","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189 (2011).","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1601_CR7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA neurology 71, 505\u2013508 (2014).","journal-title":"JAMA neurology"},{"key":"1601_CR8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204\u20131222 (2012).","journal-title":"Cell"},{"key":"1601_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol"},{"key":"1601_CR10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"1601_CR11","doi-asserted-by":"crossref","first-page":"912995","DOI":"10.3389\/fnmol.2022.912995","volume":"15","author":"M Yokoyama","year":"2022","unstructured":"Yokoyama, M., Kobayashi, H., Tatsumi, L. & Tomita, T. Mouse mdels of Alzheimer\u2019s disease. Front. Mol. Neurosci. 15, 912995 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"1601_CR12","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","volume":"99","author":"M Rapoport","year":"2002","unstructured":"Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P. & Ferreira, A. Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 99, 6364\u20136369 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1601_CR13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson, E. D. et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science 316, 750\u2013754 (2007).","journal-title":"Science"},{"key":"1601_CR14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner, L. M. et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell 142, 387\u2013397 (2010).","journal-title":"Cell"},{"key":"1601_CR15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1194653","volume":"330","author":"KA Vossel","year":"2010","unstructured":"Vossel, K. A. et al. Tau reduction prevents A\u03b2-induced defects in axonal transport. Science 330, 198 (2010).","journal-title":"Science"},{"key":"1601_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.20086","volume":"24","author":"R Rademakers","year":"2004","unstructured":"Rademakers, R., Cruts, M. & van Broeckhoven, C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum. Mutat. 24, 277\u2013295 (2004).","journal-title":"Hum. Mutat."},{"key":"1601_CR17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","volume":"25","author":"J Lewis","year":"2000","unstructured":"Lewis, J. et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402\u2013405 (2000).","journal-title":"Nat. Genet."},{"key":"1601_CR18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Ab and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"1601_CR19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476\u2013481 (2005).","journal-title":"Science"},{"key":"1601_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007).","journal-title":"Neuron"},{"key":"1601_CR21","doi-asserted-by":"crossref","first-page":"12754","DOI":"10.1074\/jbc.RA119.009487","volume":"294","author":"T Saito","year":"2019","unstructured":"Saito, T. et al. Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation. J. Biol. Chem. 294, 12754\u201312765 (2019).","journal-title":"J. Biol. Chem."},{"key":"1601_CR22","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1021\/bi00158a027","volume":"31","author":"A Andreadis","year":"1992","unstructured":"Andreadis, A., Brown, W. M. & Kosik, K. S. Structure and novel exons of the human tau gene. Biochemistry 31, 10626\u201310633 (1992).","journal-title":"Biochemistry"},{"key":"1601_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D. & Crowther, R. A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease. Neuron 3, 519\u2013526 (1989).","journal-title":"Neuron"},{"key":"1601_CR24","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0896-6273(89)90077-9","volume":"2","author":"KS Kosik","year":"1989","unstructured":"Kosik, K. S., Orecchio, L. D., Bakalis, S. & Neve, R. L. Developmentally regulated expression of specific tau sequences. Neuron 2, 1389\u20131397 (1989).","journal-title":"Neuron"},{"key":"1601_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2009.12.005","volume":"1315","author":"N Oikawa","year":"2010","unstructured":"Oikawa, N., Kimura, N. & Yanagisawa, K. Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition. Brain Res. 1315, 137\u2013149 (2010).","journal-title":"Brain Res."},{"key":"1601_CR26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0197-4580(00)00176-7","volume":"21","author":"C Schultz","year":"2000","unstructured":"Schultz, C. et al. Age-related progression of tau pathology in brains of baboons. Neurobiol. Aging 21, 905\u2013912 (2000).","journal-title":"Neurobiol. Aging"},{"key":"1601_CR27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cne.21744","volume":"509","author":"RF Rosen","year":"2008","unstructured":"Rosen, R. F. et al. Tauopathy with paired helical filaments in an aged chimpanzee. J. Comp. Neurol. 509, 259\u2013270 (2008).","journal-title":"J. Comp. Neurol."},{"key":"1601_CR28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/138161212799315885","volume":"18","author":"E Heuer","year":"2012","unstructured":"Heuer, E., Rosen, R. F., Cintron, A. & Walker, L. C. Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr. Pharm. Des. 18, 1159\u20131169 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"1601_CR29","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1074\/jbc.RA118.001784","volume":"293","author":"K Stefanoska","year":"2018","unstructured":"Stefanoska, K. et al. An N-terminal motif unique to primate tau enables differential protein-protein interactions. J. Biol. Chem. 293, 3710\u20133719 (2018).","journal-title":"J. Biol. Chem."},{"key":"1601_CR30","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1016\/S0021-9258(18)41890-X","volume":"267","author":"M Hasegawa","year":"1992","unstructured":"Hasegawa, M. et al. Protein sequence and mass spectrometric analyses of tau in the Alzheimer\u2019s disease brain. J. Biol. Chem. 267, 17047\u201317054 (1992).","journal-title":"J. Biol. Chem."},{"key":"1601_CR31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0197-4580(95)00027-C","volume":"16","author":"M Morishima-Kawashima","year":"1995","unstructured":"Morishima-Kawashima, M. et al. Hyperphosphorylation of tau in PHF. Neurobiol. Aging 16, 365\u2013371 (1995).","journal-title":"Neurobiol. Aging"},{"key":"1601_CR32","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998.71062465.x","volume":"71","author":"DP Hanger","year":"1998","unstructured":"Hanger, D. P., Betts, J. C., Loviny, T. L., Blackstock, W. P. & Anderton, B. H. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer\u2019s disease brain using nanoelectrospray mass spectrometry. J. Neurochem. 71, 2465\u20132476 (1998).","journal-title":"J. Neurochem."},{"key":"1601_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1750-3639.2007.00051.x","volume":"17","author":"J G\u00f6tz","year":"2007","unstructured":"G\u00f6tz, J. et al. A decade of tau transgenic animal models and beyond. Brain Pathol. 17, 91\u2013103 (2007).","journal-title":"Brain Pathol."},{"key":"1601_CR34","volume":"7","author":"Z Tu","year":"2017","unstructured":"Tu, Z. et al. Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos. Sci. Rep. 7, 42081 (2017).","journal-title":"Sci. Rep."},{"key":"1601_CR35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41422-019-0142-y","volume":"29","author":"W Yang","year":"2019","unstructured":"Yang, W. et al. CRISPR\/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys. Cell Res. 29, 334\u2013336 (2019).","journal-title":"Cell Res."},{"key":"1601_CR36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41421-023-00525-3","volume":"9","author":"B Li","year":"2023","unstructured":"Li, B. et al. CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate. Cell Discov. 9, 27 (2023).","journal-title":"Cell Discov."},{"key":"1601_CR37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/hmg\/ddy367","volume":"28","author":"Z Tu","year":"2019","unstructured":"Tu, Z. et al. CRISPR\/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms. Hum. Mol. Genet. 28, 561\u2013571 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"1601_CR38","doi-asserted-by":"crossref","first-page":"205846012110268","DOI":"10.1177\/20584601211026810","volume":"10","author":"Y Hoshino","year":"2021","unstructured":"Hoshino, Y. et al. Extremely low 18 F-fluorodeoxyglucose uptake in the brain of a patient with metastatic neuroblastoma and its recovery after chemotherapy: a case report. Acta Radiol. Open 10, 205846012110268 (2021).","journal-title":"Acta Radiol. Open"},{"key":"1601_CR39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia, C. F. et al. [(18)F] T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimers Dement. 9, 666\u2013676 (2013).","journal-title":"Alzheimers Dement."},{"key":"1601_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.24920\/03476","volume":"33","author":"XZ Shi","year":"2018","unstructured":"Shi, X. Z., Wei, X., Sha, L. Z. & Xu, Q. Comparison of \u03b2-amyloid plaque labeling methods: antibody staining, gallyas silver staining, and thioflavin-S staining. Chin. Med. Sci. J. 33, 167\u2013173 (2018).","journal-title":"Chin. Med. Sci. J."},{"key":"1601_CR41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/alz.12318","volume":"17","author":"D Beckman","year":"2021","unstructured":"Beckman, D. et al. A novel tau-based rhesus monkey model of Alzheimer\u2019s pathogenesis. Alzheimers Dement. 17, 933\u2013945 (2021).","journal-title":"Alzheimers Dement."},{"key":"1601_CR42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00109-008-0391-6","volume":"86","author":"A Eckert","year":"2008","unstructured":"Eckert, A. et al. Oligomeric and fibrillar species of beta amyloid (Abeta 42) both impair mitochondrial function in P301L tau transgenic mice. J. Mol. Med. 86, 1255\u20131267 (2008).","journal-title":"J. Mol. Med."},{"key":"1601_CR43","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-021-01125-y","volume":"21","author":"B Decourt","year":"2021","unstructured":"Decourt, B. et al. Critical appraisal of amyloid lowering agents in AD. Curr. Neurol. Neurosci. Rep. 21, 39 (2021).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1601_CR44","doi-asserted-by":"crossref","first-page":"870517","DOI":"10.3389\/fnagi.2022.870517","volume":"14","author":"M Shi","year":"2022","unstructured":"Shi, M., Chu, F., Zhu, F. & Zhu, J. Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab. Front. Aging Neurosci. 14, 870517 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1601_CR45","doi-asserted-by":"crossref","first-page":"848215","DOI":"10.3389\/fnins.2022.848215","volume":"16","author":"GA Krafft","year":"2022","unstructured":"Krafft, G. A., Jerecic, J., Siemers, E. & Cline, E. N. ACU193: an immunotherapeutic poised to test the amyloid \u03b2 oligomer hypothesis of Alzheimer\u2019s disease. Front. Neurosci. 16, 848215 (2022).","journal-title":"Front. Neurosci."},{"key":"1601_CR46","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"H Braak","year":"2015","unstructured":"Braak, H., Del & Tredici, K. The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease. Brain 138, 2814\u20132833 (2015).","journal-title":"Brain"},{"key":"1601_CR47","first-page":"115","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten, A. F. T., Datta, D., Tredici, K., Del, & Braak, H. Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimers Dis. 17, 115\u2013124 (2021).","journal-title":"Alzheimers Dis."},{"key":"1601_CR48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1050-3862(96)00167-2","volume":"13","author":"DR Borchelt","year":"1996","unstructured":"Borchelt, D. R. et al. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet. Anal. 13, 159\u2013163 (1996).","journal-title":"Genet. Anal."},{"key":"1601_CR49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1091581820905092","volume":"39","author":"C Ballesteros","year":"2020","unstructured":"Ballesteros, C. et al. Cerebrospinal fluid characterization in cynomolgus monkeys, beagle dogs, and G\u00f6ttingen minipigs. Int. J. Toxicol. 39, 124\u2013130 (2020).","journal-title":"Int. J. Toxicol."},{"key":"1601_CR50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","volume":"173","author":"S Yan","year":"2018","unstructured":"Yan, S. et al. A huntingtin knock-in pig model recapitulates features of selective neurodegeneration in Huntington\u2019s disease. Cell 173, 989\u20131002 (2018).","journal-title":"Cell"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01601-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T02:02:57Z","timestamp":1700272977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01601-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01601-6","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"358"}}